Article
Three assays show differences in binding of wild-type and mutant p53 to unique gene sequences.
Technology in cancer research & treatment - 1 Dec 2009
Chandrachud Uma, Gal Susannah
Abstract excerpt
Cancer-associated mutations in the p53 gene often change amino acids in the protein's DNA binding domain. We used three different binding assays specifically gel shift, DNA binding scintillation proximity assay and a streptavidin magnetic bead assay to analyze the DNA binding of the tumor suppres...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
